<VariationArchive VariationID="4858" VariationName="NM_023067.4(FOXL2):c.804dup (p.Gly269fs)" VariationType="Duplication" Accession="VCV000004858" Version="7" RecordType="classified" NumberOfSubmissions="7" NumberOfSubmitters="6" DateLastUpdated="2024-05-08" DateCreated="2013-04-04" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="19897" VariationID="4858">
      <GeneList>
        <Gene Symbol="FOXL2" FullName="forkhead box L2" GeneID="668" HGNC_ID="HGNC:1092" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>3q22.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="138944224" stop="138947137" display_start="138944224" display_stop="138947137" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="138663065" stop="138665981" display_start="138663065" display_stop="138665981" Strand="-" />
          </Location>
          <OMIM>605597</OMIM>
          <Haploinsufficiency last_evaluated="2021-02-09" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=FOXL2">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-02-09" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=FOXL2">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_023067.4(FOXL2):c.804dup (p.Gly269fs)</Name>
      <CanonicalSPDI>NC_000003.12:138945918:GGGGGG:GGGGGGG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>3q22.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="138945918" stop="138945919" display_start="138945918" display_stop="138945919" variantLength="1" positionVCF="138945918" referenceAlleleVCF="C" alternateAlleleVCF="CG" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="138664760" stop="138664761" display_start="138664760" display_stop="138664761" variantLength="1" positionVCF="138664760" referenceAlleleVCF="C" alternateAlleleVCF="CG" />
      </Location>
      <ProteinChange>G269fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.11" sequenceAccession="NC_000003" sequenceVersion="11" change="g.138664766dup" Assembly="GRCh37">
            <Expression>NC_000003.11:g.138664766dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.12" sequenceAccession="NC_000003" sequenceVersion="12" change="g.138945924dup" Assembly="GRCh38">
            <Expression>NC_000003.12:g.138945924dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012454.1" sequenceAccession="NG_012454" sequenceVersion="1" change="g.6222dup">
            <Expression>NG_012454.1:g.6222dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_029796.1" sequenceAccession="NG_029796" sequenceVersion="1" change="g.3691dup">
            <Expression>NG_029796.1:g.3691dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_023067.4" sequenceAccession="NM_023067" sequenceVersion="4" change="c.804dup" MANESelect="true">
            <Expression>NM_023067.4:c.804dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_075555.1" sequenceAccession="NP_075555" sequenceVersion="1" change="p.Gly269fs">
            <Expression>NP_075555.1:p.Gly269fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1295" sequenceAccession="LRG_1295">
            <Expression>LRG_1295:g.6222dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1295t1" sequenceAccession="LRG_1295t1">
            <Expression>LRG_1295t1:c.804dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_1295p1" sequenceAccession="LRG_1295p1" change="p.Gly269fs">
            <Expression>LRG_1295p1:p.Gly269fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="605597.0006" DB="OMIM" />
        <XRef Type="rs" ID="797044528" DB="dbSNP" />
        <XRef ID="CA212818" DB="ClinGen" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff reviewed the sequence information reported in PubMed 1468277 Fig. 2Q to determine the location of this allele on the current reference sequence.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_023067.4(FOXL2):c.804dup (p.Gly269fs) AND BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS, TYPE II" Accession="RCV000005132" Version="2">
        <ClassifiedConditionList TraitSetID="19739">
          <ClassifiedCondition DB="MedGen" ID="C2931136">BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS, TYPE II</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2003-02-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_023067.4(FOXL2):c.804dup (p.Gly269fs) AND BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS, TYPE I" Accession="RCV000005133" Version="2">
        <ClassifiedConditionList TraitSetID="19580">
          <ClassifiedCondition DB="MedGen" ID="C2931135">BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS, TYPE I</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2003-02-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_023067.4(FOXL2):c.804dup (p.Gly269fs) AND Blepharophimosis, ptosis, and epicanthus inversus syndrome" Accession="RCV000192036" Version="5">
        <ClassifiedConditionList TraitSetID="1337">
          <ClassifiedCondition DB="MedGen" ID="C0220663">Blepharophimosis, ptosis, and epicanthus inversus syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2017-01-01" SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_023067.4(FOXL2):c.804dup (p.Gly269fs) AND not provided" Accession="RCV000727228" Version="5">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-07-26" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-07-26" NumberOfSubmissions="7" NumberOfSubmitters="6" DateCreated="2013-04-04" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11468277</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">12529855</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17277738</ID>
        </Citation>
        <Citation Type="general">
          <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=FOXL2</URL>
        </Citation>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">20301614</ID>
          <ID Source="BookShelf">NBK1441</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="19580" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="8096" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Blepharophimosis, ptosis, and epicanthus inversus syndrome type 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">BPES with ovarian failure</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Blepharophimosis syndrome type 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">BPES type 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">BPES with premature ovarian failure</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Blepharophimosis, ptosis, epicanthus inversus with ovarian failure</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Blepharophimosis, ptosis, epicanthus inversus type 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">BPES I</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS, TYPE I</ElementValue>
                <XRef Type="Allelic variant" ID="605597.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="605597.0012" DB="OMIM" />
                <XRef Type="Allelic variant" ID="605597.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="605597.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="605597.0014" DB="OMIM" />
                <XRef Type="Allelic variant" ID="605597.0011" DB="OMIM" />
                <XRef Type="Allelic variant" ID="605597.0015" DB="OMIM" />
                <XRef Type="Allelic variant" ID="605597.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="605597.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="605597.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="605597.0018" DB="OMIM" />
              </Name>
              <XRef ID="C2931135" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="19739" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="7586" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">BPES without ovarian failure</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Blepharophimosis, ptosis, and epicanthus inversus syndrome type 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Blepharophimosis syndrome type 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">BPES type 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Blepharophimosis, ptosis, and epicanthus inversus type 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Blepharophimosis, ptosis, and epicanthus inversus without premature ovarian failure</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">BPES without premature ovarian failure</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS, TYPE II</ElementValue>
                <XRef Type="Allelic variant" ID="605597.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="605597.0010" DB="OMIM" />
                <XRef Type="Allelic variant" ID="605597.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="605597.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="605597.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="605597.0020" DB="OMIM" />
                <XRef Type="Allelic variant" ID="605597.0009" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">BPES II</ElementValue>
              </Symbol>
              <XRef ID="C2931136" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1337" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4679" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Blepharophimosis, ptosis, and epicanthus inversus</ElementValue>
                <XRef ID="Blepharophimosis%2C+ptosis%2C+and+epicanthus+inversus/7828" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Blepharophimosis, ptosis, and epicanthus inversus syndrome</ElementValue>
                <XRef ID="3351" DB="GeneTests" />
                <XRef ID="MONDO:0007201" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">BPES</ElementValue>
                <XRef Type="MIM" ID="110100" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Blepharophimosis, ptosis, and epicanthus inversus syndrome (BPES) is defined by a complex eyelid malformation characterized by four major features, all present at birth: blepharophimosis, ptosis, epicanthus inversus, and telecanthus. BPES type I includes the four major features and primary ovarian insufficiency; BPES type II includes only the four major features. Other ophthalmic manifestations that can be associated with BPES include dysplastic eyelids, lacrimal duct anomalies, strabismus, refractive errors, and amblyopia. Other craniofacial features may include a broad nasal bridge and low-set ears.</Attribute>
                <XRef ID="NBK1441" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="23" />
                <XRef ID="23" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301614</ID>
                <ID Source="BookShelf">NBK1441</ID>
              </Citation>
              <XRef ID="126" DB="Orphanet" />
              <XRef ID="C0220663" DB="MedGen" />
              <XRef ID="MONDO:0007201" DB="MONDO" />
              <XRef Type="MIM" ID="110100" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="25309" SubmissionDate="2012-04-17" DateLastUpdated="2013-04-04" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="605597.0006_BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS, TYPE II" title="FOXL2, 1-BP INS, 1041C_BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS, TYPE II" />
        <ClinVarAccession Accession="SCV000025309" DateUpdated="2013-04-04" DateCreated="2013-04-04" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2003-02-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 2 families with BPES II (110100), De Baere et al. (2001) found that affected members had a 1-bp cytosine insertion following position 1041, resulting in 264 novel amino acids beginning at codon 268 and extending the protein from 376 amino acids to 532 amino acids.</Attribute>
              <Citation>
                <ID Source="PubMed">11468277</ID>
              </Citation>
              <XRef DB="OMIM" ID="110100" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">De Baere et al. (2003) found this mutation in a family with BPES I. They stated that this was the first mutation shown to lead to both BPES types in different families (interfamilial phenotypic variability).</Attribute>
              <Citation>
                <ID Source="PubMed">12529855</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FOXL2" />
          </GeneList>
          <Name>FOXL2, 1-BP INS, 1041C</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP INS, 1041C</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="605597.0006" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS, TYPE II</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="25310" SubmissionDate="2012-04-17" DateLastUpdated="2013-04-04" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="605597.0006_BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS, TYPE I" title="FOXL2, 1-BP INS, 1041C_BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS, TYPE I" />
        <ClinVarAccession Accession="SCV000025310" DateUpdated="2013-04-04" DateCreated="2013-04-04" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2003-02-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to included disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 2 families with BPES II (110100), De Baere et al. (2001) found that affected members had a 1-bp cytosine insertion following position 1041, resulting in 264 novel amino acids beginning at codon 268 and extending the protein from 376 amino acids to 532 amino acids.</Attribute>
              <Citation>
                <ID Source="PubMed">11468277</ID>
              </Citation>
              <XRef DB="OMIM" ID="110100" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">De Baere et al. (2003) found this mutation in a family with BPES I. They stated that this was the first mutation shown to lead to both BPES types in different families (interfamilial phenotypic variability).</Attribute>
              <Citation>
                <ID Source="PubMed">12529855</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FOXL2" />
          </GeneList>
          <Name>FOXL2, 1-BP INS, 1041C</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP INS, 1041C</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="605597.0006" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="included">BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS, TYPE I</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="948365" SubmissionDate="2016-12-14" DateLastUpdated="2015-10-05" DateCreated="2015-10-05">
        <ClinVarSubmissionID localKey="FOXL2-50|OMIM:110100" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000484892" DateUpdated="2015-10-05" DateCreated="2015-10-05" Type="SCV" Version="1" SubmitterName="Genomic Diagnostic Laboratory, Division of Genomic Diagnostics, Children's Hospital of Philadelphia" OrgID="165021" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-11-03">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">DGD Variant Analysis Guidelines</Attribute>
          <Citation Type="general">
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/q5qzurm4/dgd_variant_analysis_guidelines.docx</URL>
            <CitationText>DGD_Variant_Analysis_Guidelines.docx</CitationText>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="3" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="VariantChromosomes" integerValue="3" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FOXL2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>p.[Gly269Argfs*265]</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_023067.3:c.804dupC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="110100" Type="MIM" />
          </Trait>
        </TraitSet>
        <StudyDescription>Clinical Testing</StudyDescription>
        <Comment>Clinical Testing</Comment>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1379162" SubmissionDate="2018-09-19" DateLastUpdated="2018-12-15" DateCreated="2015-10-05">
        <ClinVarSubmissionID localKey="60166_000000" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000706764" DateUpdated="2018-12-15" DateCreated="2015-10-05" Type="SCV" Version="2" SubmitterName="Eurofins Ntd Llc (ga)" OrgID="500060" OrganizationCategory="laboratory" OrgAbbreviation="EGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-03-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">EGL Classification Definitions 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/ahdynye1/egl_classification_definitions_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <Gender>mixed</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FOXL2" />
          </GeneList>
          <VariantType>Duplication</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="3" alternateAllele="GG" referenceAllele="G" start="138664761" stop="138664761" variantLength="1" />
            <GeneLocation>NM_023067.3:Ex1</GeneLocation>
          </Location>
          <XRefList>
            <XRef DB="HGMD" ID="CI012558" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <Citation>
          <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=FOXL2</URL>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB4534263</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1807773" SubmissionDate="2019-03-08" DateLastUpdated="2019-06-23" DateCreated="2019-06-23">
        <ClinVarSubmissionID localKey="c.804dup" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000924437" DateUpdated="2019-06-23" DateCreated="2019-06-23" Type="SCV" Version="1" SubmitterName="Wessex Regional Genetics Laboratory, Salisbury District Hospital" OrgID="506925" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-01-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>de novo</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
            </Sample>
            <Method>
              <TypePlatform>Sanger sequencing</TypePlatform>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
          <ObservedIn>
            <Sample>
              <Origin>paternal</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
            </Sample>
            <Method>
              <TypePlatform>Sanger sequencing</TypePlatform>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
            </Sample>
            <Method>
              <TypePlatform>Sanger sequencing</TypePlatform>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
            </Sample>
            <Method>
              <TypePlatform>Sanger sequencing</TypePlatform>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FOXL2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>p.(Gly269ArgfsTer265)</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_023067.3:c.804dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="110100" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5295063</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="372430" SubmissionDate="2015-02-05" DateLastUpdated="2022-10-01" DateCreated="2015-10-05">
        <ClinVarSubmissionID localKey="NM_023067.3:c.804dupC|OMIM:110100" />
        <ClinVarAccession Accession="SCV000207362" DateUpdated="2022-10-01" DateCreated="2015-10-05" Type="SCV" Version="2" SubmitterName="GeneReviews" OrgID="500062" OrganizationCategory="resource" OrgAbbreviation="GeneReviews" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no classification provided</ReviewStatus>
          <GermlineClassification>not provided</GermlineClassification>
          <Citation>
            <ID Source="BookShelf">NBK1441</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FOXL2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>NP_075555.1:p.Gly269ArgfsTer265</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_023067.3:c.804dupC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0220663" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11808016</SubmissionName>
          <SubmissionName>epb42-spherocytosis_4-24-2014</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7978876" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2024-02-14">
        <ClinVarSubmissionID localKey="4846828|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004293514" DateUpdated="2024-02-14" DateCreated="2024-02-14" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-07-26">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">17277738</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11468277</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Gly269Argfs*265) in the FOXL2 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 108 amino acid(s) of the FOXL2 protein. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This premature translational stop signal has been observed in individual(s) with blepharophimosis (PMID: 17277738). ClinVar contains an entry for this variant (Variation ID: 4858). This variant disrupts a region of the FOXL2 protein in which other variant(s) (p.Ala304Hisfs*52) have been determined to be pathogenic (PMID: 11468277). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FOXL2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000003.11:g.138664760_138664761insG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1807773" TraitType="Disease" MappingType="XRef" MappingValue="110100" MappingRef="OMIM">
        <MedGen CUI="C0220663" Name="Blepharophimosis, ptosis, and epicanthus inversus syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1379162" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="948365" TraitType="Disease" MappingType="XRef" MappingValue="110100" MappingRef="OMIM">
        <MedGen CUI="C0220663" Name="Blepharophimosis, ptosis, and epicanthus inversus syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7978876" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="25310" TraitType="Disease" MappingType="Name" MappingValue="BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS, TYPE I" MappingRef="Alternate">
        <MedGen CUI="C2931135" Name="BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS, TYPE I" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="372430" TraitType="Disease" MappingType="XRef" MappingValue="C0220663" MappingRef="MedGen">
        <MedGen CUI="C0220663" Name="Blepharophimosis, ptosis, and epicanthus inversus syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="25309" TraitType="Disease" MappingType="Name" MappingValue="BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS, TYPE II" MappingRef="Preferred">
        <MedGen CUI="C2931136" Name="BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS, TYPE II" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

